Amneal Pharmaceuticals (AMRX) Research & Development (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Research & Development of $38.4 million for Q1 2026, down 4.14% year-over-year from $40.0 million in Q1 2025, and up 10.24% quarter-over-quarter from $34.8 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Research & Development (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Research & Development history runs 10 years deep, the most recent figure standing at $38.4 million for Q1 2026.
- In Q1 2026, Research & Development fell 4.14% year-over-year to $38.4 million; the TTM figure through Mar 2026 stood at $184.5 million (down 3.62% YoY), while the FY2025 annual figure was $186.2 million, down 2.38% from the prior year.
- Research & Development for Q1 2026 stood at $38.4 million, up from $34.8 million in the prior quarter.
- The five-year high for Research & Development was $63.4 million in Q3 2025, with the low at $34.8 million in Q4 2025.
- The 5-year median for Research & Development is $41.9 million (2022), against an average of $45.6 million.
- The sharpest annual moves came in 2024 and 2025: Research & Development surged 47.67% in 2024, then plunged 35.84% in 2025.
- Amneal Pharmaceuticals' Research & Development stood at $41.9 million in 2022, then gained by 9.97% to $46.1 million in 2023, then gained by 17.75% to $54.3 million in 2024, then plunged by 35.84% to $34.8 million in 2025, then increased by 10.24% to $38.4 million in 2026.
- Business Quant data shows AMRX's Research & Development at $38.4 million in Q1 2026, $34.8 million in Q4 2025, and $63.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 39.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.02 Mn |
| Mar 31, 2026 | 38.38 Mn |
| Dec 31, 2025 | 34.82 Mn |
| Sep 30, 2025 | 63.35 Mn |
| Jun 30, 2025 | 47.96 Mn |
| Mar 31, 2025 | 40.04 Mn |
| Dec 31, 2024 | 54.27 Mn |
| Sep 30, 2024 | 61.10 Mn |
| Jun 30, 2024 | 36.05 Mn |
| Mar 31, 2024 | 39.30 Mn |
| Dec 31, 2023 | 46.09 Mn |
| Sep 30, 2023 | 41.38 Mn |
| Jun 30, 2023 | 37.80 Mn |
| Mar 31, 2023 | 38.69 Mn |
| Dec 31, 2022 | 41.91 Mn |
| Sep 30, 2022 | 50.24 Mn |
| Jun 30, 2022 | 50.75 Mn |
| Mar 31, 2022 | 52.80 Mn |
| Dec 31, 2021 | 51.87 Mn |
| Sep 30, 2021 | 48.93 Mn |